2019 Miami Neuro Symposium Post-Survey | Baptist Health CME

How confident are you in your ability to: *

5 = High level of competence 4 = Moderately high level of competence 3 = Average level of competence 2 = Low level of competence 1 = No level of competence

	5	4	3	2	1
Properly select patients who are candidates for IV TPA and/or endovascular treatment.	Properly select patients who are candidates for IV TPA and/or endovascular treatment. - 5	Properly select patients who are candidates for IV TPA and/or endovascular treatment. - 4	Properly select patients who are candidates for IV TPA and/or endovascular treatment. - 3	Properly select patients who are candidates for IV TPA and/or endovascular treatment. - 2	Properly select patients who are candidates for IV TPA and/or endovascular treatment. - 1
Properly manage imaging workup in patients presenting with symptoms and signs of acute ischemic stroke.	Properly manage imaging workup in patients presenting with symptoms and signs of acute ischemic stroke. - 5	Properly manage imaging workup in patients presenting with symptoms and signs of acute ischemic stroke. - 4	Properly manage imaging workup in patients presenting with symptoms and signs of acute ischemic stroke. - 3	Properly manage imaging workup in patients presenting with symptoms and signs of acute ischemic stroke. - 2	Properly manage imaging workup in patients presenting with symptoms and signs of acute ischemic stroke. - 1
Recognize the advantages and disadvantages of CTA and CT perfusion in acute ischemic stroke.	Recognize the advantages and disadvantages of CTA and CT perfusion in acute ischemic stroke. - 5	Recognize the advantages and disadvantages of CTA and CT perfusion in acute ischemic stroke. - 4	Recognize the advantages and disadvantages of CTA and CT perfusion in acute ischemic stroke. - 3	Recognize the advantages and disadvantages of CTA and CT perfusion in acute ischemic stroke. - 2	Recognize the advantages and disadvantages of CTA and CT perfusion in acute ischemic stroke. - 1
Apply a comprehensive medical treatment approach to reduce the incidence of stroke for secondary prevention.	Apply a comprehensive medical treatment approach to reduce the incidence of stroke for secondary prevention. - 5	Apply a comprehensive medical treatment approach to reduce the incidence of stroke for secondary prevention. - 4	Apply a comprehensive medical treatment approach to reduce the incidence of stroke for secondary prevention. - 3	Apply a comprehensive medical treatment approach to reduce the incidence of stroke for secondary prevention. - 2	Apply a comprehensive medical treatment approach to reduce the incidence of stroke for secondary prevention. - 1
Identify “rare” causes of stroke and properly manage these conditions.	Identify “rare” causes of stroke and properly manage these conditions. - 5	Identify “rare” causes of stroke and properly manage these conditions. - 4	Identify “rare” causes of stroke and properly manage these conditions. - 3	Identify “rare” causes of stroke and properly manage these conditions. - 2	Identify “rare” causes of stroke and properly manage these conditions. - 1
Implement safety of procedures used for intracranial endovascular interventional treatment of cerebrovascular diseases.	Implement safety of procedures used for intracranial endovascular interventional treatment of cerebrovascular diseases. - 5	Implement safety of procedures used for intracranial endovascular interventional treatment of cerebrovascular diseases. - 4	Implement safety of procedures used for intracranial endovascular interventional treatment of cerebrovascular diseases. - 3	Implement safety of procedures used for intracranial endovascular interventional treatment of cerebrovascular diseases. - 2	Implement safety of procedures used for intracranial endovascular interventional treatment of cerebrovascular diseases. - 1
Properly manage hematologic disorders associated with stroke.	Properly manage hematologic disorders associated with stroke. - 5	Properly manage hematologic disorders associated with stroke. - 4	Properly manage hematologic disorders associated with stroke. - 3	Properly manage hematologic disorders associated with stroke. - 2	Properly manage hematologic disorders associated with stroke. - 1
Identify common risk factors for PRES, RCVS and vasculitis.	Identify common risk factors for PRES, RCVS and vasculitis. - 5	Identify common risk factors for PRES, RCVS and vasculitis. - 4	Identify common risk factors for PRES, RCVS and vasculitis. - 3	Identify common risk factors for PRES, RCVS and vasculitis. - 2	Identify common risk factors for PRES, RCVS and vasculitis. - 1
Distinguish primary from secondary headaches.	Distinguish primary from secondary headaches. - 5	Distinguish primary from secondary headaches. - 4	Distinguish primary from secondary headaches. - 3	Distinguish primary from secondary headaches. - 2	Distinguish primary from secondary headaches. - 1
Properly classify and manage Parkinson’s disease, essential tremors and dystonia.	Properly classify and manage Parkinson’s disease, essential tremors and dystonia. - 5	Properly classify and manage Parkinson’s disease, essential tremors and dystonia. - 4	Properly classify and manage Parkinson’s disease, essential tremors and dystonia. - 3	Properly classify and manage Parkinson’s disease, essential tremors and dystonia. - 2	Properly classify and manage Parkinson’s disease, essential tremors and dystonia. - 1
Properly classify and manage neuromuscular disorders, ALS and dementia.	Properly classify and manage neuromuscular disorders, ALS and dementia. - 5	Properly classify and manage neuromuscular disorders, ALS and dementia. - 4	Properly classify and manage neuromuscular disorders, ALS and dementia. - 3	Properly classify and manage neuromuscular disorders, ALS and dementia. - 2	Properly classify and manage neuromuscular disorders, ALS and dementia. - 1
Recognize the pharmacological basis of the anti-seizure effects of cannabidiol defined for some epileptic syndromes.	Recognize the pharmacological basis of the anti-seizure effects of cannabidiol defined for some epileptic syndromes. - 5	Recognize the pharmacological basis of the anti-seizure effects of cannabidiol defined for some epileptic syndromes. - 4	Recognize the pharmacological basis of the anti-seizure effects of cannabidiol defined for some epileptic syndromes. - 3	Recognize the pharmacological basis of the anti-seizure effects of cannabidiol defined for some epileptic syndromes. - 2	Recognize the pharmacological basis of the anti-seizure effects of cannabidiol defined for some epileptic syndromes. - 1

Leave this field blank